- Home
- CFND vs INMB Comparison
CFND vs INMB Comparison
Compare CFND & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFND | INMB |
|---|---|---|
| Founded | N/A | 2015 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 40.1M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CFND | INMB |
|---|---|---|
| Price | $4.16 | $1.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | N/A | ★ 324.9K |
| Earning Date | N/A | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | N/A | $1.38 |
| 52 Week High | N/A | $11.64 |
Technical Indicators
Market Signals| Indicator | CFND | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 49.78 |
| Support Level | $3.82 | $1.41 |
| Resistance Level | $4.73 | $1.74 |
| Average True Range (ATR) | 0.25 | 0.12 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 24.59 | 48.72 |
Price Performance
Historical ComparisonAbout CFND C1 Fund Inc.
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.